An analysis of DNA samples showed the gene-inactivating mutation to be present in all modern humans worldwide.
In two of the families, the copy number change was the second mutation to be characterized.
We used engineered nucleases (meganuclease or TALE nuclease) to induce a DSB located at 90 bp of the mutation to be corrected.
In both families, the copy number change was the second mutation to be characterized and shown to have been inherited from one of the healthy carrier parents.
To be able to reuse the initial design primer library, it is important to ensure that the fixed mutation (first mutation) does not overlap with the primer pair used for the mutation to be introduced (second mutation).
In drug-resistant TB, isoniazid resistance was overwhelmingly the initial resistance mutation to be acquired, which would not be detected by current rapid molecular diagnostics employed in South Africa that assess only rifampicin resistance.
Dr. Cherr said it would be relatively simple to develop a test for the mutation to be performed in a clinic or at home.
We found the frequency of the K70R mutation to be higher in patients treated with ZDV/ddI (P=0.033) or ZDV/ddC (P=0.3) when compared with patients treated with ZDV/3TC.
For a mutation to be carcinogenic, it must occur near, and affect, a growth-regulating gene called an oncogene.
Lin et al. calculated the rate of PCR-induced mutation to be 1.18×10−4 errors/bp [30].
The first such mutation to be identified was in GUCA1A encoding Guanylate Cyclase Activating Protein 1 (GCaP1), a component of the phototransduction cascade [3].
